• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

80 岁及以上口服抗凝剂治疗的心房颤动患者营养状况与安全性和疗效结局的关系。

Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants.

机构信息

Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan.

Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan.

出版信息

J Cardiol. 2021 Feb;77(2):147-153. doi: 10.1016/j.jjcc.2020.10.008. Epub 2020 Oct 22.

DOI:10.1016/j.jjcc.2020.10.008
PMID:33371946
Abstract

BACKGROUND

Malnutrition has been reported to be associated with worse clinical outcomes in various cardiovascular diseases. We aimed to investigate the clinical significance of the nutritional status in atrial fibrillation (AF) patients aged 80 years and over receiving oral anticoagulants (OACs), focusing on the difference between direct OACs (DOACs) and warfarin treatment.

METHODS

This was a retrospective and observational study. We enrolled 332 consecutive AF patients aged 80 years and over who were treated with OACs: DOACs (n = 256) and warfarin (n = 76). A controlling nutritional status (CONUT) score was used to evaluate the nutritional status. The enrolled patients were divided into two groups based on the CONUT score: CONUT score <5 (n = 239) and CONUT score ≥5 (n = 93) groups. We investigated the relationship between the nutritional status and clinical outcomes.

RESULTS

The CONUT score ≥5 group had significantly higher incidence of major bleeding (MB) compared to the CONUT score <5 group (4.6/100 person-years vs. 0.7/100 person-years, p < 0.01). On Cox hazard analysis, CONUT score ≥5 group was significantly associated with increased MB compared with the CONUT score <5 group (hazard ratio: 5.80, 95% confidence interval: 1.44-23.33, p = 0.013). In the DOAC group, the incidence of MB did not differ between the CONUT score ≥5 and CONUT score <5 groups (p = 0.54). In the warfarin group, MB occurred more frequently in the CONUT score ≥5 group than CONUT score <5 group (p < 0.01). There was no significant difference in the incidence of thromboembolic events between the CONUT score ≥5 and CONUT score <5 groups in both the DOAC and warfarin groups.

CONCLUSIONS

The prognostic values of the nutritional status based on the CONUT score for MB differed between AF patients aged 80 years and over receiving DOACs and those receiving warfarin. It may be favorable to use DOACs to avoid bleeding events in those with malnutrition.

摘要

背景

营养不良与各种心血管疾病的临床结局恶化有关。我们旨在研究 80 岁及以上接受口服抗凝剂(OAC)治疗的心房颤动(AF)患者的营养状况的临床意义,重点关注直接口服抗凝剂(DOAC)与华法林治疗之间的差异。

方法

这是一项回顾性和观察性研究。我们纳入了 332 名连续接受 OAC 治疗的 80 岁及以上的 AF 患者:DOAC(n=256)和华法林(n=76)。使用控制营养状况(CONUT)评分评估营养状况。根据 CONUT 评分将入组患者分为两组:CONUT 评分<5(n=239)和 CONUT 评分≥5(n=93)组。我们研究了营养状况与临床结局之间的关系。

结果

CONUT 评分≥5 组的大出血(MB)发生率明显高于 CONUT 评分<5 组(4.6/100 人年与 0.7/100 人年,p<0.01)。Cox 风险分析显示,与 CONUT 评分<5 组相比,CONUT 评分≥5 组的 MB 发生风险显著增加(风险比:5.80,95%置信区间:1.44-23.33,p=0.013)。在 DOAC 组中,CONUT 评分≥5 组与 CONUT 评分<5 组之间的 MB 发生率无差异(p=0.54)。在华法林组中,CONUT 评分≥5 组的 MB 发生率高于 CONUT 评分<5 组(p<0.01)。在 DOAC 和华法林组中,CONUT 评分≥5 组与 CONUT 评分<5 组的血栓栓塞事件发生率均无显著差异。

结论

基于 CONUT 评分的营养状况对 80 岁及以上接受 DOAC 和华法林治疗的 AF 患者的 MB 预后价值不同。使用 DOAC 可能有利于避免营养不良患者的出血事件。

相似文献

1
Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants.80 岁及以上口服抗凝剂治疗的心房颤动患者营养状况与安全性和疗效结局的关系。
J Cardiol. 2021 Feb;77(2):147-153. doi: 10.1016/j.jjcc.2020.10.008. Epub 2020 Oct 22.
2
Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.血糖状况与房颤患者的血栓栓塞和大出血风险。
Cardiovasc Diabetol. 2020 Mar 10;19(1):30. doi: 10.1186/s12933-020-01005-8.
3
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.直接口服抗凝剂和华法林治疗心房颤动患者的处方模式和结局:真实世界分析。
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29.
4
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.直接口服抗凝剂与华法林在非瓣膜性心房颤动中的围手术期结局。
Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457.
5
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.八旬老年房颤患者中直接口服抗凝剂与维生素 K 拮抗剂的临床特征:一项多中心倾向评分匹配真实世界队列研究。
J Thromb Thrombolysis. 2020 Jan;49(1):42-53. doi: 10.1007/s11239-019-01923-9.
6
Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.90 岁及以上年龄的心房颤动患者口服抗凝药的影响:直接口服抗凝药、华法林抗凝药和非抗凝治疗的比较。
J Cardiovasc Pharmacol. 2019 Sep;74(3):246-254. doi: 10.1097/FJC.0000000000000703.
7
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).在临床实践中,非维生素K拮抗剂口服抗凝剂与华法林治疗心房颤动患者大出血的管理比较(来自心房颤动更明智治疗结果登记处[ORBIT-AF II]的第二阶段)
Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28.
8
Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.比较病态肥胖人群中房颤患者直接口服抗凝剂与华法林的疗效和安全性。
Ann Pharmacother. 2019 Feb;53(2):165-170. doi: 10.1177/1060028018796604. Epub 2018 Aug 22.
9
Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHADS-VASc score.基于 CHADS-VASc 评分的亚洲房颤患者口服抗凝药物的净临床获益。
BMC Cardiovasc Disord. 2023 Dec 19;23(1):623. doi: 10.1186/s12872-023-03643-8.
10
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.直接口服抗凝剂与维生素 K 拮抗剂在合并生物瓣心脏瓣膜的心房颤动患者中的临床获益比较。
Clin Ther. 2019 Dec;41(12):2549-2557. doi: 10.1016/j.clinthera.2019.10.008. Epub 2019 Nov 14.

引用本文的文献

1
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation.心房颤动患者中与多种疾病、虚弱和营养不良相关的不良临床结局。
J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29.
2
Lymphocyte-to-C-reactive protein ratio and score in patients with heart failure: Nutritional status, physical function, and prognosis.心力衰竭患者的淋巴细胞与C反应蛋白比值及评分:营养状况、身体功能和预后
ESC Heart Fail. 2024 Dec;11(6):3723-3731. doi: 10.1002/ehf2.14972. Epub 2024 Jul 10.
3
Trends in Anticoagulant Utilization and Clinical Outcomes for Cancer-Associated Thrombosis: A Multicenter Cohort Study in Thailand's Upper-Middle-Income Country Setting.
癌症相关血栓形成抗凝治疗的趋势及临床结局:泰国中上收入国家多中心队列研究。
JCO Glob Oncol. 2024 Feb;10:e2300353. doi: 10.1200/GO.23.00353.
4
Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009-18).老年房颤患者不适当联合抗血小板和抗凝治疗:随时间变化趋势(2009 - 2018年)
Drugs Aging. 2023 Mar;40(3):273-283. doi: 10.1007/s40266-023-01006-8. Epub 2023 Feb 23.
5
Low alanine aminotransferase levels are independently associated with mortality risk in patients with atrial fibrillation.低丙氨酸氨基转移酶水平与房颤患者的死亡风险独立相关。
Sci Rep. 2022 Jul 16;12(1):12183. doi: 10.1038/s41598-022-16435-5.
6
Impaired brain activity in patients with persistent atrial fibrillation assessed by near-infrared spectroscopy and its changes after catheter ablation.经近红外光谱评估持续性心房颤动患者的脑活动受损及其导管消融后的变化。
Sci Rep. 2022 May 12;12(1):7866. doi: 10.1038/s41598-022-12097-5.